Intended use
This ELISA kit is intended for use in quantitating Carboxypeptidase B, recombinant from Rattus norvegicus. The kit is for research use only and is not intended for diagnostic use in human or animals.
This Carboxypeptidase B assay is a two-site immuno enzymetric assay. The recombinant Carboxypeptidase B from Rattus norvegicus, expressed in E.Coli, from YAXINBIO, in the samples are reacted in micro titer wells coated with a purified capture antibody. An anti-Carboxypeptidase B monoclonal antibody conjugated with the enzyme horseradish peroxidase (HRP) is reacted simultaneously forming a sandwich complex of solid phase antibody-Carboxypeptidase B-HRP labeled antibody. After a wash step to remove any unbound reactants, the wells are then reacted with tetramethylbenzidine (TMB) substrate. The amount of hydrolyzed substrate is read on a microtiter plate reader and will be directly proportional to the concentration of recombinant Carboxypeptidase B present in the samples. Accurate quantitation is achieved by comparing the signal of recombinant Carboxypeptidase B standards assayed at the same time.
Vial cap |
Label |
Contents |
Storage |
|
Anti-Carboxypeptidase B Coated plate Dismountable Micro ELISA Plate in a sealed bag |
8 wells×12 Strips |
-20°C |
A1 |
Carboxypeptidase B Standard (lyophilizates) |
4×32 ng |
2-8°C |
A2 (125×) |
HRP Conjugated Anti-Carboxypeptidase B Concentrate Mouse monoclonal Antibody to recombinant Carboxypeptidase B conjugated to HRP in a protein matrix with preservatives |
1×0.1 mL |
-20°C |
P1 |
Diluent Concentrate (25×) For Standard& Samples |
1×5 mL |
2-8°C |
P2 |
Wash Concentrate (25×) |
1×40 mL |
2-8°C |
A3 |
TMB Substrate 3,3’,5,5Tetramethylbenzidine |
5×0.125 mL |
-20°C Avoid Light |
P3 |
TMB Diluent (Substrate Reagent) |
1×15 mL |
2-8°C Avoid Light |
P4 |
Stop Solution |
1×5 mL |
2-8°C |
|
Plate Sealer (Reuseable) |
5 sheets |
|
|
Product Insert |
1 |
|
|
Certificate of Analysis |
1 |
|
YAXINBIO has validated the assay by conventional criteria as indicated below.
The lower limit of detection (LOD) is defined as that concentration corresponding to a signal two standard deviations above the mean of the zero standard. LOD is ~141 pg/mL in the recommended protocol. The lower limit of quantitation (LOQ) is defined as the lowest concentration, where concentration coefficients of variation (CVs) are <20%. The LOQ is ~250 pg/mL.
Precision is defined as the percent coefficient of variation (%CV). This is calculated by dividing the standard deviation by the mean value for a number of replicate determinations of two different control samples in the low and high concentration range of the assay. Both intra-assay and inter-assay precision were determined on 2 pools with low (~2.0 ng/mL) and high concentrations (~16.0 ng/mL).
Intra-assay
Number of Test |
X (ng/ml) |
% CV |
20 |
2.0 |
7.2 |
20 |
16.0 |
3.6 |
Inter-assay
Number of Assays |
X (ng/ml) |
% CV |
8 |
2.0 |
8.4 |
8 |
16.0 |
5.2 |
Substances |
Concentration tested |
human plasma |
Undiluted |
human serum |
Undiluted |
LB medium |
Undiluted |
Recombinant Trypsin in E.Coli |
1 mg/ml |
Carboxypeptidase B from other suppliers other than YAXINBIO may show a different reactivity with regard to sensitivity and accuracy; therefore, the compatibility of the kit calibration to the individual Carboxypeptidase B product must be verified.
Although the assay is designed to minimize matrix interference, certain sample matrices may interfere in this assay. Materials, such as detergents and salt in high concentration, extremes of pH (<6.0 and >8.5) or very high protein concentrations may give erroneous results. It is recommended to test the sample matrix for interference by diluting the 10 ng/mL standard to analyze the recovery.
High Dose Hook Effect may be observed in samples
with very high concentrations of recombinant Carboxypeptidase B. The readings of samples greater than 32 ng/mL (80 ng,100 ng,500 ug/mL) may give absorbance less than 60 ng/mL standard. It is highly recommended that samples should be assayed by diluted, when their readings were ≧32 ng/ml.
Precision on duplicate samples should yield average coefficients of variation of less than 10% for samples greater than 1 ng/mL. CVs for samples <1 ng/mL may be greater than 10%. It is recommended that each laboratory assay appropriate quality control samples in each run to insure that all reagents and procedures are correct.
Incubation time: 1 h 45 min to 2 hours
Total assay time: approximately 2 to 2.5 hours
With deionized or distilled water in a ratio of 1:25, bring Diluents Concentrate (P1, 25×) for Standard, Samples & HRP-Ab to working Diluents.
Dilute Wash Concentrate (P2, 25×) with deionized or distilled water in the proportion of 1:25 to make working Wash Buffer. If crystals have formed in the concentrate, warm it in 40°C water bath and mix it gently, until the crystals have completely dissolved.
Dilute the Concentrated HRP Conjugate (A2,125×) in a proportion of 1:125 with P1. Based on the required amount (100 μL/well), extra amount of 100~200 μL is recommended.
Dilute TMB substrate (A3, 20×) with P3 in a ratio of 1:20 to make a working solution (A3).
Dry against clean absorbent paper. Repeat this wash step 3 times.
Note:
X-Contentes (ng/mL) |
32 |
16 |
8 |
4 |
2 |
1 |
0.5 |
0 |
Y-OD450/650nm |
1.816 |
1.370 |
0.801 |
0.403 |
0.227 |
0.150 |
0.114 |
0.081 |
Recovery (ng/mL) |
32.02 |
15.97 |
8.05 |
3.92 |
2.02 |
1.06 |
0.54 |
— |
Recovery (%) |
100.1 |
99.8 |
100.6 |
98.0 |
101.0 |
106.0 |
108.0 |
— |
Experimental Data
Request Information |
Other Products |
Related Products |
Recently viewed products |